NanoVibronix (NASDAQ:NAOV)soars 23.4% premarket in reaction to the announcement that it intends to enter the Over-the-Counter (OTC) pain relief market with the introduction of PainShield RELIEF, a non-prescription ultrasound therapy device that delivers fast pain relief for nerve and soft tissue damage.
Plans are under way for an official launch in the U.S. and select parts of the world and product reveal in the coming months.
The company expects widespread availability by early to mid-2022.
The company has submitted its trademark application to the USPTO for protection of the PainShield RELIEF and expects to submit for clearance to the FDA in very near term.